Overview
Riuko Ohashi practices in Niigata, Japan. Ohashi is rated as an Experienced expert by MediFind in the treatment of Hyperparathyroidism. Their top areas of expertise are Chromophobe Renal Cell Carcinoma, Renal Oncocytoma, Renal Cell Carcinoma (RCC), and Sclerosing Mesenteritis.
Their clinical research consists of co-authoring 74 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 2 articles in the study of Hyperparathyroidism.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Chromophobe Renal Cell Carcinoma
- Advanced
- Renal Cell Carcinoma (RCC)
- Renal OncocytomaOhashi isAdvanced. Learn about Renal Oncocytoma.
- Experienced
- Budd-Chiari SyndromeOhashi isExperienced. Learn about Budd-Chiari Syndrome.
- ChickenpoxOhashi isExperienced. Learn about Chickenpox.
- Cushing's diseaseOhashi isExperienced. Learn about Cushing's disease.
- End-Stage Renal Disease (ESRD)Ohashi isExperienced. Learn about End-Stage Renal Disease (ESRD).
- Head and Neck Squamous Cell Carcinoma (HNSCC)
- HemangiomaOhashi isExperienced. Learn about Hemangioma.